Principles of Hemoperfusion Lecture Slides PDF

Summary

This document presents lecture slides on the principles of hemoperfusion, covering topics such as solute clearance, limitations of dialyzers, and the role of drug pharmacokinetics. It discusses different therapies like convection and diffusion, and mentions various factors affecting the procedure and its application in clinical settings. The document provides information on different types of cartridges and analysis of ibuprofen and naproxen.

Full Transcript

Principles of Hemoperfusion JD Foster, VMD, MS, DACVIM, DACVCP Overview Limitations of solute removal in IHD/CRRT Rationale of hemoperfusion Relevant pharmacology Solute Clearance in IHD/CRRT Solutes are cleared from intravascular space Properties of...

Principles of Hemoperfusion JD Foster, VMD, MS, DACVIM, DACVCP Overview Limitations of solute removal in IHD/CRRT Rationale of hemoperfusion Relevant pharmacology Solute Clearance in IHD/CRRT Solutes are cleared from intravascular space Properties of solute and membrane determine clearance Diffusion- based on concentration gradients Diffusion Limitations Limited by pore size of dialyzer – Conventional (Low-flux): ~300 daltons – High-Flux: 12-15,000 daltons Clearance limited by Qb and Qd – IHD vs. CRRT PD has less clearance than that achieved with other ERRT Molecular F3 F160 Size KOA urea 230 1064 K urea 60 da 125 194 (Qb 200, Qd 500) K creat 113 da 95 181 (Qb 200, Qd 500) K B12 1355 da 20 128 (Qb 200, Qd 500) Limited Solute Clearance in IHD/CRRT Limited by pharmacokinetics of drug – Lipid solubility – Protein binding – Volume of distribution Convection- pressure applied to blood Convective Therapies Diffusion and convection have similar clearance of smaller MW molecules (0.6L/kg suggests high lipophilicity, protein or tissue binding – In people, a Vd >1–2 L/kg is usually a deterrent to extracorporeal removal T ½- endogenous elimination Protein, lipid binding- reduces free solute Intercompartmental transfer rates Studied dose vs. toxic dose Clinical Indications for HP of Toxins Winchester JF. Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther. 2002. 9 (1): 26- 30. When to Choose HP Winchester JF. Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther. 2002. 9 (1): 26- 30. Solute Kinetics in HP If no saturation of filter, 1st-order kinetics would occur Cartridge Saturation Solute Kinetics in HP C = Qb (1 – Hct) x [(Ca – Cv)] Ca Qb= blood flow Ca= pre-cartridge concentration Cv= post-cartridge concentration Compartmental Kinetics One-compartment: body is single compartment -Vd is distribution volume -Occurs when Vd = treatment volume ---Drug found mostly within blood volume Compartmental Kinetics Blood Fat Two-compartment: body is divided into multiple compartments -Blood, tissues, etc. -Solute moves between compartments ---Solute may be more concentrated in one compartment (e.g. fat) ---Solute removal may be limited by redistribution to intravascular space 2 Compartment Solute Kinetics Eq High intercompartmental transfer rate 2 Compartment Solute Kinetics Moderate peripheral compartment Large peripheral compartment Cartridge Saturation Adsorba saturated after 1-6 hours for most solutes Atlas- higher surface area, longer to saturate DATA!!! Cartridges must be replaced when saturated Adsorba Adsorba (Baxter) 150 – 110ml priming volume Tauk & Foster JVECC 2016 Hour Arterial Post Post Dialyzer % reduction % reduction Charcoal C D 0 228 1 139 149 147 7.19 1.34 2 56.2 106 161 [-88.61] [-51.88] 3.5 157 108 70.8 31.21 34.44 4.25 58 55.8 51 3.79 8.60 5 38.9 44.8 68.3 [-15.16] [-52.45] 6 47.6 43.6 39.1 8.40 10.32 Ibuprofen concentrations Naproxen Concentrations During 5hr Charcoal Hemoperfusion Tx 120 Naproxen Concentration (ppm) 100 80 60 Arterial Blood 40 Concentration 20 0 0 20 40 60 80 100 120 140 Time (hours) Charcoal HP + HD Naproxen concentrations AimaLojic Carbon Cartridges Atlas (150 - 5,000 Da) and Dublin (150 - 45,000 Da) – 100 and 300 size cartridges – 41mL and 165mL priming volumes – 55k m2 surface area (>10 football fields) 5.3 kg DSH 46 mg/kg naproxen ingestion Carbon HP started 8 hr after exposure AKI: sCr 3.5 → 1.3 Regenerative anemia: 2x pRBC 99% reduction VetResQ Reduction in IL-6, IL-8, IL-1 Improved survival in non-controlled trials 300ml, 150ml, 50ml priming volumes Cytokines Vetresq.com IL-6 C-Reactive Protein Heymann Crit Care Med 2023 No survival benefit of CytoSorb® use in septic people at 28 - 30 days Saldaña-Gastulo Crit Care Sci 2023 Other Adsorptive Therapies Polymer sorbents – Can be customizable Albumin dialysis MARS (molecular adsorbent recirculating system) Prometheus MARS System Plasmapheresis & Adsorption Prometheus and MARS Systems Prometheus MARS Tsipotis Adv Chronic Kidney Dis 2015 Questions?

Use Quizgecko on...
Browser
Browser